- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Exact Sciences ramps up colon cancer outreach to Hispanic community with Carlos Ponce partnership | ||
| Di | Ideaya hires Gilead leader to head up commercialization push | ||
| Di | Taking its best shot at Roche, Merck scores in phase 3 trial of subcutaneous Keytruda | ||
| Di | NeuroBo Pharmaceuticals rebrands to become MetaVia | ||
| Di | Despite fears over RFK Jr. pick, industry should focus more on FDA job: analyst | ||
| Mo | Skills shortage still holding back pharma's digital transformation: survey | ||
| Mo | Sanofi lays out €40M to beef up transplant, diabetes drug production in France | ||
| Mo | Syndax scores FDA approval for Revuforj after it disappointed in another acute leukemia indication | ||
| Mo | VBI Vaccines recalls hepatitis B shot as it winds down operations | ||
| Mo | With new patient resource to close conversation gaps in rheumatic disease, AbbVie makes 'Rheum for Dialogue' | ||
| Mo | Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome | ||
| Mo | Amid Seattle downsizing, Gilead cuts 100+ positions at California HQ | ||
| Mo | Cleanup for the IL-23 class in ulcerative colitis as new drugs 'rapidly gained significant momentum': report | ||
| 15.11. | AbbVie doles out awards to support career goals of 20 people living with migraines | ||
| 15.11. | Vaccine stocks sag in US, Europe after RFK Jr.'s HHS appointment | ||
| 15.11. | After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas | ||
| 15.11. | FDA nod for Azurity's Danziten will allow patients to take leukemia med without fasting | ||
| 15.11. | EU regulators endorse meds from BMS, J&J, Eisai and more-plus a clutch of biosims | ||
| 15.11. | Dexcom taps Nick Jonas, other stars for World Diabetes Day push | ||
| 15.11. | Fierce Pharma Asia-Merck and BioNTech's I-O bispecific buys; AstraZeneca CEO's China defense | ||
| 15.11. | With RFK Jr. appointment for HHS, biopharma industry could face powerful adversary in government | ||
| 14.11. | Citing 'capacity constraints,' Novo Nordisk plots global wind-down of human insulin pen production | ||
| 14.11. | EMA changes tack, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population | ||
| 14.11. | PTC wins FDA approval for first brain-delivered gene therapy Kebilidi | ||
| 14.11. | Merck joins American Lung Association in raising awareness of pulmonary arterial hypertension |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
